Yannan Yuan

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

Xiaotian Zhang, Liang Han, Ziyu Li et al. · The Lancet Oncology · 2021 · 440 citations

Medicine, Oncology, Surgery +17

Incidence and mortality of stomach cancer in China, 2014

Lei Yang, Rongshou Zheng, Ning Wang et al. · Chinese Journal of Cancer Research · 2018 · 197 citations

Medicine, Health Sciences, Oncology +16

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial

Xiaotian Zhang, Liang Han, Ziyu Li et al. · The Lancet Oncology · 2025 · 49 citations

Medicine, Oncology, Surgery +16

[Analysis of Incidence and Mortality of Thyroid Cancer in China, 2013].

Lei Yang, Rongshou Zheng, Ning Wang et al. · PubMed · 2017 · 32 citations

Medicine, Endocrinology, Oncology +17

Burden of lung cancer attributable to ambient fine particles and potential benefits from air quality improvements in Beijing, China: A population-based study

Lei Yang, Tao Xue, Ning Wang et al. · The Science of The Total Environment · 2020 · 30 citations · Full text

Public Health, Health Sciences, Population Health Sciences +17